QQ客服 官方微博 反馈留言

	Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
	Li, Chunlin[1]; Zhang, Nengpan[2]; Zhou, Jundong[3]; Ding, Chen[4]; Jin, Yaqing[5]; Cui, Xueyuan[6]; Pu, Kefeng[7]; Zhu, Yimin[8]
刊名	CANCER IMMUNOLOGY RESEARCH
	2018
卷号	6页码:178-188
ISSN号	2326-6066
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2180253
专题	上海大学
作者单位	1.[1]Chinese Acad Sci, CAS Key Lab Nano Biointerface, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China. 2.Univ Chinese Acad Sci, Beijing, Peoples R China. 3.[2]Chinese Acad Sci, CAS Key Lab Nano Biointerface, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China. 4.[3]Nanjing Med Univ, Affiliated Suzhou Hosp, Dept Radio Oncol, Suzhou, Peoples R China. 5.[4]Chinese Acad Sci, CAS Key Lab Nano Biointerface, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China. 6.China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China. 7.[5]Chinese Acad Sci, CAS Key Lab Nano Biointerface, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China. 8.Univ Chinese Acad Sci, Beijing, Peoples R China. 9.[6]Chinese Acad Sci, CAS Key Lab Nano Biointerface, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China. 10.Shanghai Univ, Shanghai, Peoples R China.
推荐引用方式 GB/T 7714	Li, Chunlin[1],Zhang, Nengpan[2],Zhou, Jundong[3],et al. Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy[J]. CANCER IMMUNOLOGY RESEARCH,2018,6:178-188.
APA	Li, Chunlin[1].,Zhang, Nengpan[2].,Zhou, Jundong[3].,Ding, Chen[4].,Jin, Yaqing[5].,...&Zhu, Yimin[8].(2018).Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy.CANCER IMMUNOLOGY RESEARCH,6,178-188.
MLA	Li, Chunlin[1],et al."Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy".CANCER IMMUNOLOGY RESEARCH 6(2018):178-188.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。